Niagen Bioscience, Inc.
NAGE
Revenue
33.84M
▼-147.00k▼-0.4325%
3 Months ChangeAssets
106.41M
▲8.27M▲8.42%
3 Months ChangeLiabilities
29.87M
▲2.41M▲8.78%
3 Months ChangeFree Cash Flow
-5.24M
▼-1.95M▼-59.29%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-04
Form 8-K
ID: 0001386570-26-000014
2026-02-26
Form 8-K
ID: 0001386570-26-000003
2025-12-22
Form 8-K
ID: 0001386570-25-000030
2025-11-06
Form 8-K
ID: 0001386570-25-000025
2025-11-04
Form 8-K
ID: 0001386570-25-000021
2025-11-04
Form 10-Q
ID: 0001386570-25-000020
2025-10-06
Form 8-K
ID: 0001386570-25-000015
2025-08-06
Form 8-K
ID: 0001386570-25-000011
2025-08-06
Form 10-Q
ID: 0001386570-25-000010
2025-07-29
Form 8-K
ID: 0001628280-25-036445